Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021

Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021

Thyroid cancer is among the most common malignancies in the US, with a 3.6% annual increase in incidence over the past 50 years. Treatment regimens for thyroid cancer are well-established, with excellent survival outcomes. However, costs of thyroid cancer care can vary substantially by hospital and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2021-07, Vol.326 (2), p.184-185
Hauptverfasser: Xiao, Roy, Rathi, Vinay K, Gross, Cary P, Ross, Joseph S, Sethi, Rosh K. V
Format: Artikel
Sprache:eng
Schlagworte:
Bankruptcy
Cancer
Letter
Letters
Medical diagnosis
Online First
Research Letter
Thyroid
Thyroid cancer
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 185
container_issue 2
container_start_page 184
container_title JAMA : the journal of the American Medical Association
container_volume 326
creator Xiao, Roy
Rathi, Vinay K
Gross, Cary P
Ross, Joseph S
Sethi, Rosh K. V
description Thyroid cancer is among the most common malignancies in the US, with a 3.6% annual increase in incidence over the past 50 years. Treatment regimens for thyroid cancer are well-established, with excellent survival outcomes. However, costs of thyroid cancer care can vary substantially by hospital and impose significant financial burdens on patients2; among patients with cancer, bankruptcy rates are highest for those with thyroid cancer.
doi_str_mv 10.1001/jama.2021.8535
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8278265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2780946</ama_id><sourcerecordid>2537638114</sourcerecordid><originalsourceid>FETCH-LOGICAL-a437t-40049f0af1989e73cea9e3bbc8db7936e8a83436db67c15f1ad0c4ea58c8ee523</originalsourceid><addsrcrecordid>eNpdkc1v1DAQxS0EotvClQMHZIkLlyz-TJwLElooILVQpHK2Js5k16uNXews0v73dbRtReuLD_N7T2_mEfKGsyVnjH_cwghLwQRfGi31M7LgWppK6tY8JwvGWlM1yqgTcprzlpXHZfOSnEjFTM20WJDfV3DAVP3EdZw8TNjTq-QdZuoDnTZIv3hYh5h9phB6egkB1jhimGgc6PXmkKLv6QqCwzQr5iCvyIsBdhlf3_1n5M_51-vV9-ri17cfq88XFSjZTJViTLUDg4G3psVGOoQWZdc503dNK2s0YKSSdd_VjeN64NAzpxC0cQZRC3lGPh19b_bdiL0roRLs7E3yI6SDjeDt40nwG7uO_6wRjRG1LgYf7gxS_LvHPNnRZ4e7HQSM-2yFlk0tDeeqoO-foNu4T6GsVyitleC1mA2XR8qlmHPC4SEMZ3Zuy85t2flIdm6rCN79v8IDfl9PAd4egVl3Py3xWatqeQuuU5hZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2555421625</pqid></control><display><type>article</type><title>Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021</title><source>American Medical Association Journals</source><creator>Xiao, Roy ; Rathi, Vinay K ; Gross, Cary P ; Ross, Joseph S ; Sethi, Rosh K. V</creator><creatorcontrib>Xiao, Roy ; Rathi, Vinay K ; Gross, Cary P ; Ross, Joseph S ; Sethi, Rosh K. V</creatorcontrib><description>Thyroid cancer is among the most common malignancies in the US, with a 3.6% annual increase in incidence over the past 50 years. Treatment regimens for thyroid cancer are well-established, with excellent survival outcomes. However, costs of thyroid cancer care can vary substantially by hospital and impose significant financial burdens on patients2; among patients with cancer, bankruptcy rates are highest for those with thyroid cancer.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2021.8535</identifier><identifier>PMID: 34086052</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Bankruptcy ; Cancer ; Letter ; Letters ; Medical diagnosis ; Online First ; Research Letter ; Thyroid ; Thyroid cancer</subject><ispartof>JAMA : the journal of the American Medical Association, 2021-07, Vol.326 (2), p.184-185</ispartof><rights>Copyright American Medical Association Jul 13, 2021</rights><rights>Copyright 2021 American Medical Association. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a437t-40049f0af1989e73cea9e3bbc8db7936e8a83436db67c15f1ad0c4ea58c8ee523</citedby><cites>FETCH-LOGICAL-a437t-40049f0af1989e73cea9e3bbc8db7936e8a83436db67c15f1ad0c4ea58c8ee523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2021.8535$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.8535$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,314,777,781,882,3327,27905,27906,76238,76241</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34086052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xiao, Roy</creatorcontrib><creatorcontrib>Rathi, Vinay K</creatorcontrib><creatorcontrib>Gross, Cary P</creatorcontrib><creatorcontrib>Ross, Joseph S</creatorcontrib><creatorcontrib>Sethi, Rosh K. V</creatorcontrib><title>Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>Thyroid cancer is among the most common malignancies in the US, with a 3.6% annual increase in incidence over the past 50 years. Treatment regimens for thyroid cancer are well-established, with excellent survival outcomes. However, costs of thyroid cancer care can vary substantially by hospital and impose significant financial burdens on patients2; among patients with cancer, bankruptcy rates are highest for those with thyroid cancer.</description><subject>Bankruptcy</subject><subject>Cancer</subject><subject>Letter</subject><subject>Letters</subject><subject>Medical diagnosis</subject><subject>Online First</subject><subject>Research Letter</subject><subject>Thyroid</subject><subject>Thyroid cancer</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpdkc1v1DAQxS0EotvClQMHZIkLlyz-TJwLElooILVQpHK2Js5k16uNXews0v73dbRtReuLD_N7T2_mEfKGsyVnjH_cwghLwQRfGi31M7LgWppK6tY8JwvGWlM1yqgTcprzlpXHZfOSnEjFTM20WJDfV3DAVP3EdZw8TNjTq-QdZuoDnTZIv3hYh5h9phB6egkB1jhimGgc6PXmkKLv6QqCwzQr5iCvyIsBdhlf3_1n5M_51-vV9-ri17cfq88XFSjZTJViTLUDg4G3psVGOoQWZdc503dNK2s0YKSSdd_VjeN64NAzpxC0cQZRC3lGPh19b_bdiL0roRLs7E3yI6SDjeDt40nwG7uO_6wRjRG1LgYf7gxS_LvHPNnRZ4e7HQSM-2yFlk0tDeeqoO-foNu4T6GsVyitleC1mA2XR8qlmHPC4SEMZ3Zuy85t2flIdm6rCN79v8IDfl9PAd4egVl3Py3xWatqeQuuU5hZ</recordid><startdate>20210713</startdate><enddate>20210713</enddate><creator>Xiao, Roy</creator><creator>Rathi, Vinay K</creator><creator>Gross, Cary P</creator><creator>Ross, Joseph S</creator><creator>Sethi, Rosh K. V</creator><general>American Medical Association</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210713</creationdate><title>Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021</title><author>Xiao, Roy ; Rathi, Vinay K ; Gross, Cary P ; Ross, Joseph S ; Sethi, Rosh K. V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a437t-40049f0af1989e73cea9e3bbc8db7936e8a83436db67c15f1ad0c4ea58c8ee523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Bankruptcy</topic><topic>Cancer</topic><topic>Letter</topic><topic>Letters</topic><topic>Medical diagnosis</topic><topic>Online First</topic><topic>Research Letter</topic><topic>Thyroid</topic><topic>Thyroid cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xiao, Roy</creatorcontrib><creatorcontrib>Rathi, Vinay K</creatorcontrib><creatorcontrib>Gross, Cary P</creatorcontrib><creatorcontrib>Ross, Joseph S</creatorcontrib><creatorcontrib>Sethi, Rosh K. V</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xiao, Roy</au><au>Rathi, Vinay K</au><au>Gross, Cary P</au><au>Ross, Joseph S</au><au>Sethi, Rosh K. V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2021-07-13</date><risdate>2021</risdate><volume>326</volume><issue>2</issue><spage>184</spage><epage>185</epage><pages>184-185</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><abstract>Thyroid cancer is among the most common malignancies in the US, with a 3.6% annual increase in incidence over the past 50 years. Treatment regimens for thyroid cancer are well-established, with excellent survival outcomes. However, costs of thyroid cancer care can vary substantially by hospital and impose significant financial burdens on patients2; among patients with cancer, bankruptcy rates are highest for those with thyroid cancer.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>34086052</pmid><doi>10.1001/jama.2021.8535</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 2021-07, Vol.326 (2), p.184-185
issn 0098-7484
1538-3598
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8278265
source American Medical Association Journals
subjects Bankruptcy
Cancer
Letter
Letters
Medical diagnosis
Online First
Research Letter
Thyroid
Thyroid cancer
title Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A41%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Payer-Negotiated%20Prices%20in%20the%20Diagnosis%20and%20Management%20of%20Thyroid%20Cancer%20in%202021&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Xiao,%20Roy&rft.date=2021-07-13&rft.volume=326&rft.issue=2&rft.spage=184&rft.epage=185&rft.pages=184-185&rft.issn=0098-7484&rft.eissn=1538-3598&rft_id=info:doi/10.1001/jama.2021.8535&rft_dat=%3Cproquest_pubme%3E2537638114%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2555421625&rft_id=info:pmid/34086052&rft_ama_id=2780946&rfr_iscdi=true